Table 5. Treatment modalities.
| Variable | Frequency | Percentage |
|---|---|---|
|
Chemotherapy Neoadjuvant Adjuvant Total |
40 338 378 |
10.6 89.4 100 |
|
Nature of chemotherapy CAF CMF Taxanes AC Others Total |
160 100 2 91 25 378 |
42.3 26.5 0.5 24.1 6.6 100 |
|
Radiotherapy Neo-adjuvant Adjuvant Total |
5 373 378 |
1.3 98.7 100 |
|
Mode of surgery BCS Mastectomy Total |
50 328 378 |
13.2 86.8 100 |
|
Axillary clearance No Yes Total |
124 254 378 |
32.8 67.2 100 |
|
Hormonal treatment No Yes Total |
138 240 378 |
36.5 63.5 100 |
CMF: Cyclophosphamide, Methotrexate, 5-FU; AC: Adriamycin, Cyclophosphamide